Fig. 5

Effects of CSBTA and paclitaxel on primary DRG neurons viability. At 4th days, CSBTA (0, 0.05, 0.5, 5, 50 μg/ml) and paclitaxel (0, 10, 100, 500, 1000 nM) were administered for 5 days, respectively. The absorbance value at 450 nm was measured. The data were presented as means ± SD, n = 6. ^##p < 0.01, ^#p < 0.05 compared with the blank group; *p < 0.05, **p < 0.01 compared with paclitaxel group